evo真人视讯

The Fifth Group of Liaoning Provincial People's Congress Deputies from Shenyang Visits Shenyang Cell Valley for Research and Guidance, Empowering High-Quality Development of the Life and Health Indust

Date:11-19  Hits:  Belong to:News

Recently, the Fifth Group of Liaoning Provincial People's Congress Deputies from Shenyang conducted a thematic research visit to the Shenyang Economic and Technological Development Zone, visiting Shenyang Cell Valley Biopharmaceutical Co., Ltd. to conduct an on-site inspection of its cell and gene therapy (CGT) innovation and R&D platform. Zhang Baosheng, General Manager of Shenyang Cell Valley, and Wang Wenjuan, Head of the Marketing Department, accompanied and received the delegation.

图片.png

Shenyang Cell Valley is a joint venture established by Shenzhen Cell Valley Group and the state-owned platform Shenyang Zhongdekai Life Technology Co., Ltd. It is a key biopharmaceutical project introduced by Shenyang International Life and Health City, dedicated to building a comprehensive cell industry platform integrating cell preparation, storage, quality testing, technology R&D, and clinical translation.

During the research visit, the delegation first toured the Shenyang Cell Valley smart exhibition hall, receiving a detailed briefing on the company's development history, national strategic layout, core technology platforms, clinical translation achievements, and the construction progress of the Shenyang Cell Valley project. Subsequently, the delegation conducted on-site visits to the newly completed cell production, cell storage, and biochemical testing laboratories, gaining a detailed understanding of the laboratories' functional layout, facility and equipment configuration, quality management system, and subsequent operational plans.

图片.png

Zhang Baosheng, General Manager of Shenyang Cell Valley, extended a warm welcome to the delegation. He noted that Shenyang Cell Valley will fully leverage the Group's accumulated technology, talent, industrial, and medical resources in the cell and gene therapy field, continuously deepening medical-industry-academia-research collaborative cooperation with local medical institutions, universities and research institutes, and industry partners in Shenyang. It will accelerate the implementation and translation of frontier innovative technologies and industrial projects in Shenyang, and, leveraging the comprehensive industrial ecosystem of Shenyang International Life and Health City, support the innovative development of the regional biopharmaceutical industry.

This research visit represents a concrete practice of People's Congress deputies going to the front lines, entering industrial parks, and gaining on-site understanding of the development of key industrial projects. Going forward, Shenyang Cell Valley will take the project's completion and commissioning as a new starting point, continuously improving platform functions and enhancing operational service capabilities, accelerating the introduction of high-quality technologies, high-end talent, and industrial resources. Leveraging the industrial advantages of Shenyang International Life and Health City, it will make every effort to support Shenyang in building a regionally influential innovation hub for cell and gene therapy and contribute to the high-quality development of Shenyang's life and health industry.


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@rodael.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Cell Valley Group is a leading CGT infrastructure platform in China. We capitalize on the strategic window opened by Decree No. 818 to bridge the gap between clinical research and commercialization.

We pioneer the "Hospital to Industry" (H2I) model. Basically, we act as the core partner for hospitals, providing a one-stop solution for new biomedical tech—covering process development, GMP manufacturing, QC, and commercial rollout. Our mission is to push China's CGT sector from pure R&D into a standardized, scalable industry.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书:(粤)-非经营性-2022-0426  Technical Support:YouDian Software